Bush Tia L — SEC Form 4 filings

SEC reporting owner CIK 1863418. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.

Transaction summary — filings shown

Covers all 13 filings on record, filed 2024-02-02 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Centessa Pharmaceuticals plc (CNTA)Chief Technology & Quality Ofc138 legs · 203,216 sh · $4,709,13631

Form 4 filings — Bush Tia L

FiledFormIssuerReported transactionsSource
2026-06-244Centessa Pharmaceuticals plc (CNTA)Disposition to issuer (D): 147,954 · Disposition to issuer (D): 360,338 (derivative) · Disposition to issuer (D): 140,000 (derivative) · Disposition to issuer (D): 27,187 (derivative) · Disposition to issuer (D): 145,208 (derivative) · Disposition to issuer (D): 125,000 (derivative) · +1 moreEDGAR
2026-02-034Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 8,549 @ $24.57 · Grant/award (A): 35,000 @ $0 · Grant/award (A): 140,000 (derivative) @ $0EDGAR
2025-11-184Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 40,000 @ $9.42 · Sale (S): 40,000 @ $28 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2025-11-134Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 40,000 @ $9.42 · Sale (S): 40,000 @ $26 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2025-09-244Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 35,000 @ $9.42 · Sale (S): 35,000 @ $24 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2025-09-114Centessa Pharmaceuticals plc (CNTA)Option exercise (M): 24,792 @ $8.01 · Sale (S): 24,792 @ $20 · Option exercise (M): 25,000 @ $9.42 · Sale (S): 25,000 @ $22 · Option exercise (M): 24,792 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2025-02-044Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 8,693 @ $16.92 · Sale (S): 11,000 @ $16.86 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2024-12-314Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 6,419 @ $16.35EDGAR
2024-12-174Centessa Pharmaceuticals plc (CNTA)Sale (S): 9,611 @ $16.36 · Option exercise (M): 17,813 @ $3.85 · Sale (S): 17,813 @ $18 · Option exercise (M): 17,813 (derivative) @ $0EDGAR
2024-10-024Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 6,419 @ $15.79EDGAR
2024-07-024Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 6,419 @ $9.03EDGAR
2024-04-024Centessa Pharmaceuticals plc (CNTA)Tax withholding (F): 6,419 @ $11.30EDGAR
2024-02-024Centessa Pharmaceuticals plc (CNTA)Grant/award (A): 42,500 @ $0 · Tax withholding (F): 3,862 @ $8.19 · Grant/award (A): 170,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1863418 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →